<DOC>
	<DOCNO>NCT01521455</DOCNO>
	<brief_summary>The purpose study prove HCP0910 therapeutically equivalent Seretide 250 Diskus repeatedly dose Asthmatic patient .</brief_summary>
	<brief_title>Therapeutic Equivalence Study HCP0910 250/50 Mcg Seretide 250 Diskus Asthmatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>age 20 ~ 75 inclusive Asthmatic diagnosis 12 week screen day Shows 12 % increase , 200mL increase FEV1 measure Visit 2 Maintain control asthma 4 week screen Diagnosed severe asthmatic patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>